Advanced Radiation Centers of New York Granted Prestigious Membership to The Radiation Therapy Oncology Group
Advanced Radiation Centers of New York (ARC), the leader in Radiation Oncology technology in the Metropolitan New York region, was approved as a participating member of the Radiation Therapy Oncology Group (RTOG), a national clinical cooperative group funded by the National Cancer Institute (NCI) to increase the survival and improve the quality of life of patients diagnosed with cancer.
“To be granted membership to the RTOG is a testament to the dedication we show to our patients day in and day out,” says Dr. Shawn H. Zimberg, Medical Director of Radiation Oncology for Advanced Radiation Centers of New York. “Being a participating member of the RTOG is both a great honor and responsibility. Our patients will gain access to clinical trials not available via any other source, and we will be able to provide them with the very best in clinical research opportunities."
ARC has been recognized as an Affiliate Member of Emory University for the Radiation Therapy Oncology Group. In order to be approved for membership, RTOG conducts a thorough examination of each practice including personnel, equipment, clinical material, physics requirements, and records. In addition, the institution must have an Institutional Review Board (IRB) and a Federal Wide Assurance (FWA) approved by the National Institutes of Health (NIH) Office for Human Research Protections (OHRP). All members are reassessed each year in order to ensure these requirements are still met.
RTOG works to improve the survival outcome and quality of life of adults with cancer by conducting of high-quality clinical trials. The cooperative group, which ARC is now a member of, evaluates new forms of radiotherapy delivery in the context of clinical research.
Kristie Galvani
HJMT Public Relations Inc.
631-393-0220
kristie@hjmt.com
About The Radiation Therapy Oncology Group
The Radiation Therapy Oncology Group (RTOG) is a national clinical cooperative group funded by the National Cancer Institute (NCI) since 1968 to increase the survival and improve the quality of life of patients diagnosed with cancer. The primary areas of research for RTOG investigators are: brain tumors, head and neck cancer, lung cancer, cancers of the gastrointestinal system (esophagus, pancreas, rectum, anal canal and stomach), genitourinary tract cancers (bladder and prostate), sarcomas, gynecologic cancer (cervix) and breast cancer. The Group consists of both clinical and laboratory investigators from over 360 institutions across the United States and Canada and includes in its membership nearly 90% of all NCI-designated comprehensive and clinical cancer centers. The Group Headquarters and Statistical Unit are located in the Philadelphia offices of the American College of Radiology.
About Advanced Radiation Centers of New York
Advanced Radiation Centers of New York (ARC), a division of Integrated Medical Professionals, is a leader in Radiation Oncology technology, treatment and delivery within the Metropolitan New York region. ARC is the largest freestanding Radiation Oncology practice in New York State. ARC has six facilities across the region, providing state-of-the-art technology with the highest level of experience and compassionate care in the suburban New York community. The radiation oncologists of Advanced Radiation Centers treat more cancer patients than any other private physician practice and most hospitals in the region.
For more information about ARC visit http://advancedradiationcenters.com.
Tags: